Rock Springs Capital Management’s Kura Oncology KURA Stock Holding History

Rock Springs Capital Management’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-822,500	Closed	-$15.4M	–	143
2021 Q3	$15.4M	Buy	822,500 +5,700	+0.7%	+$107K	0.32%	83
2021 Q2	$17M	Buy	816,800 +106,765	+15%	+$2.65M	0.34%	84
2021 Q1	$20.1M	Buy	710,035 +201,919	+40%	+$6.39M	0.44%	73
2020 Q4	$16.6M	Buy	+508,116	New	+$17.9M	0.35%	88
2018 Q4	–	Sell	-405,000	Closed	-$7.09M	–	140
2018 Q3	$7.09M	Buy	405,000 +5,000	+1%	+$95.9K	0.26%	98
2018 Q2	$7.28M	Buy	400,000 +373,500	+1,409%	+$6.33M	0.28%	101
2018 Q1	$497K	Buy	+26,500	New	+$516K	0.02%	149

Other funds holding KURA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Rock Springs Capital Management's KURA Position: Q4 2021 in Review

Rock Springs Capital Management sold out of Kura Oncology (KURA) in Q4 2021, closing a stake of 822,500 shares — an estimated $15.4M sold.

Rock Springs Capital Management first reported a position in KURA in Q1 2018 and held it in 7 quarters. The position peaked at $20.1M in Q1 2021. 151 funds tracked by Wall St. Rank hold KURA as of Q4 2021.

Rock Springs Capital Management reported no remaining Kura Oncology position as of Q4 2021 after selling out during the quarter.
Rock Springs Capital Management sold 822,500 Kura Oncology shares in Q4 2021, an estimated $15.4M.
Rock Springs Capital Management first reported a position in Kura Oncology in Q1 2018 and held it in 7 quarters.
Rock Springs Capital Management's Kura Oncology position peaked at $20.1M in Q1 2021.
151 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2021.

Based on Rock Springs Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.